Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew S Davids

Showing results (1-10 of 224) with videos related to

Pageof 23
Sort By:
Blood|November 23, 2023
Functional cure reported in CLLMatthew S Davids
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
Highlights in chronic lymphocytic leukemia from the 62nd American Society of Hematology Annual Meeting and Exposition: commentaryMatthew S Davids
Blood|July 21, 2017
Targeting BCL-2 in B-cell lymphomasMatthew S Davids
Hematology. American Society of Hematology. Education Program|December 10, 2017
How should we sequence and combine novel therapies in CLL?Matthew S Davids
Clinical Advances in Hematology & Oncology : H&O|August 2, 2023
Management of Richter transformationMatthew S Davids
Lancet (London, England)|April 20, 2020
Acalabrutinib for the initial treatment of chronic lymphocytic leukaemiaMatthew S Davids
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2025
BRUIN 313 and 314 Trials Open the Door for Noncovalent Bruton Tyrosine Kinase Inhibition as Initial Therapy for Chronic Lymphocytic LeukemiaMatthew S Davids
Blood|February 22, 2014
Boldly Targeting Kinases without mutationsMatthew S Davids
Blood|May 4, 2019
Venetoclax: R-CHOP rocket booster?Charles Herbaux, Matthew S Davids
Leukemia & Lymphoma|October 20, 2020
Idelalisib in indolent NHL - has it finally found its niche?Aswin Sekar, Matthew S Davids
Pageof 23

Showing results (1-10 of 224) with videos related to

Sort By:
Pageof 23
Blood|November 23, 2023
Functional cure reported in CLLMatthew S Davids
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
Highlights in chronic lymphocytic leukemia from the 62nd American Society of Hematology Annual Meeting and Exposition: commentaryMatthew S Davids
Blood|July 21, 2017
Targeting BCL-2 in B-cell lymphomasMatthew S Davids
Hematology. American Society of Hematology. Education Program|December 10, 2017
How should we sequence and combine novel therapies in CLL?Matthew S Davids
Clinical Advances in Hematology & Oncology : H&O|August 2, 2023
Management of Richter transformationMatthew S Davids
Lancet (London, England)|April 20, 2020
Acalabrutinib for the initial treatment of chronic lymphocytic leukaemiaMatthew S Davids
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2025
BRUIN 313 and 314 Trials Open the Door for Noncovalent Bruton Tyrosine Kinase Inhibition as Initial Therapy for Chronic Lymphocytic LeukemiaMatthew S Davids
Blood|February 22, 2014
Boldly Targeting Kinases without mutationsMatthew S Davids
Blood|May 4, 2019
Venetoclax: R-CHOP rocket booster?Charles Herbaux, Matthew S Davids
Leukemia & Lymphoma|October 20, 2020
Idelalisib in indolent NHL - has it finally found its niche?Aswin Sekar, Matthew S Davids
Pageof 23